Alternative therapies in health and medicine · 2025
Anhydrous Aluminum Potassium Sulfate Reverses Post-Surgical Chronic Non-Healing Ulcer and Sensory Mononeuropathy: A Case Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kirubakaran J P Magesh, Shrivastav Pooja, Sangeetha R, Ghatbandhe Sampada Narayan
Аннотация
BACKGROUND: Chronic non-healing ulcers (CNUs), particularly those complicated by neuropathy and multi-morbidity, represent a profound therapeutic challenge with limited effective interventions. This case study investigates the novel application of topical anhydrous aluminum potassium sulfate (AAPS), a traditional astringent agent, for a refractory postsurgical ulcer with concomitant saphenous neuropathy.
CASE PRESENTATION: A 65-year-old male with poorly-controlled type 2 diabetes mellitus, schizophrenia, and severe alcohol use disorder, presented with a three-year-old, post-surgical CNU inferior to the right medial malleolus. The ulcer had failed multiple courses of targeted intravenous and oral antibiotics and was not amenable to a planned skin graft due to psychosocial constraints. Clinical and neurophysiological examination confirmed severe sensory mononeuropathy of the right saphenous nerve with Utah Early Neuropathy Scale (UENS) score of 9/12.
THERAPEUTIC INTERVENTION AND OUTCOME: After exhaustive conventional therapy failed, a protocol of once-daily topical AAPS dusting powder was initiated alongside phased mechanical debridement. The intervention resulted in complete ulcer closure within 60 days, with a 57% reduction in surface area observed by day 30. Critically, the patient reported the return of protective sensation (pain) at day 30, and the UENS score improved significantly to 3/12 post-treatment, indicating neurological recovery. No recurrence was noted during a six-month surveillance period.
CONCLUSION: This first-reported case demonstrates AAPS dusting as a highly effective intervention for complex CNUs, achieving both tissue repair and neurological recovery. The clinical outcomes align with recent evidence of AAPS-mediated ERK pathway inhibition, suggesting a potential molecular mechanism for its therapeutic action in chronic wounds. These dramatic results warrant controlled trials to validate efficacy and the mechanistic pathways.
KEYWORDS: anhydrous aluminum potassium sulfate, chronic non-healing ulcer, ERK pathway, nerve regeneration, wound healing.
CASE PRESENTATION: A 65-year-old male with poorly-controlled type 2 diabetes mellitus, schizophrenia, and severe alcohol use disorder, presented with a three-year-old, post-surgical CNU inferior to the right medial malleolus. The ulcer had failed multiple courses of targeted intravenous and oral antibiotics and was not amenable to a planned skin graft due to psychosocial constraints. Clinical and neurophysiological examination confirmed severe sensory mononeuropathy of the right saphenous nerve with Utah Early Neuropathy Scale (UENS) score of 9/12.
THERAPEUTIC INTERVENTION AND OUTCOME: After exhaustive conventional therapy failed, a protocol of once-daily topical AAPS dusting powder was initiated alongside phased mechanical debridement. The intervention resulted in complete ulcer closure within 60 days, with a 57% reduction in surface area observed by day 30. Critically, the patient reported the return of protective sensation (pain) at day 30, and the UENS score improved significantly to 3/12 post-treatment, indicating neurological recovery. No recurrence was noted during a six-month surveillance period.
CONCLUSION: This first-reported case demonstrates AAPS dusting as a highly effective intervention for complex CNUs, achieving both tissue repair and neurological recovery. The clinical outcomes align with recent evidence of AAPS-mediated ERK pathway inhibition, suggesting a potential molecular mechanism for its therapeutic action in chronic wounds. These dramatic results warrant controlled trials to validate efficacy and the mechanistic pathways.
KEYWORDS: anhydrous aluminum potassium sulfate, chronic non-healing ulcer, ERK pathway, nerve regeneration, wound healing.